Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 2

Status

Completed 4Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Dermatologic 7Other neoplasm 1

Conditions

Keratosis, Actinic 7Keratosis 3Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neoplasms 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Burkitt Lymphoma 1

Interventions

3-ingenyl angelate 42Aminolevulinic Acid 34Imiquimod 29Fluorouracil 23Photochemotherapy 22methyl 5-aminolevulinate 14Gels 12Diclofenac 12Cryotherapy 12tirbanibulin 7Solutions 7BF-200 ALA 6calcipotriene 5Petrolatum 5Ointments 5LEO 43204 5Radiotherapy 4Prilocaine 4Lidocaine 4Therapeutics 3Niacinamide 3Cryosurgery 3Biopsy 31-phenyl-3,3-dimethyltriazene 3Tomography, Optical Coherence 2SR-T100 2Phototherapy 2Imipramine 2Deoxyribonuclease (Pyrimidine Dimer) 2Celecoxib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Keratosis, Actinic × tirbanibulin × Dermatologic × Clear all
NCT07273656 2026-05-22

TIRBACRYO

University Hospital, Lille

Phase 3 Not yet recruiting
59 enrolled
Dermatologic

Keratosis, Keratosis, Actinic

NCT06135415 2026-03-25

TirbAKare

Almirall, S.A.

Phase 3 Completed
280 enrolled
DermatologicOther neoplasm

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT05387525 2025-02-11

AKtive

Almirall, S.A.

Phase 4 Active not recruiting
447 enrolled
Dermatologic

Keratosis, Actinic

NCT05260073 2024-09-20

PROAK

Almirall, S.A.

Completed
300 enrolled 9 charts
Dermatologic

Keratosis, Actinic

NCT06026358 2024-05-30

Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands

Medical University of Graz

Phase 4 Withdrawn
Dermatologic

Keratosis, Actinic

NCT05900258 2023-11-14

SunDamage

Medical University of Graz

Phase 4 Completed
22 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡